Compositions and methods for combination antiviral therapy

Details for Australian Patent Application No. 2004206827 (hide)

Owner Gilead Sciences, Inc.

Inventors Dahl, Terrence C.; Menning, Mark M.; Oliyai, Reza

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004206827

PCT Pub. Number WO2004/064846

Priority 60/440,308 14.01.03 US; 60/440,246 14.01.03 US

Filing date 13 January 2004

Wipo publication date 5 August 2004

International Classifications

A61K 031/675 - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 031/513 - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

Event Publications

21 July 2005 PCT application entered the National Phase

  PCT publication WO2004/064846 Priority application(s): WO2004/064846

5 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004206829-Long acting insulin for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with Type 2 Diabetes

2004206826-Methods for making oxidation resistant polymeric material